how many people in the us take glp 1 12% of Americans have used GLP-1 weight loss drugs About one in nine Americans

SMALL MOLECULE ORAL GLP-1 RECEPTOR AGONISTS IN DEVELOPMENT With the established beneficial clinical profile of GLP-1 receptor agonist class, considerable efforts to develop GLP-1 receptor agonists in a noninjectable formulation are garnering attention

(PDF) Palermo

Early GLP-1 drugs like exenatide required twice-daily injections and achieved more modest weight loss

For most people, the benefits of Mounjaro for weight loss or lower blood sugar levels outweigh these temporary side effects

That weight loss can, in turn, make blood sugar easier to control

[DOI] [PMC free article] [PubMed] [Google Scholar] 16.Aroda VR, Rosenstock J, Terauchi Y, Altuntas Y, Lalic NM, Morales Villegas EC, et al